LIST OF WITNESSES TO APPEAR BEFORE
COMMITTEE ON WAYS AND MEANS
SUBCOMMITTEE ON HEALTH
ON SENIOR'S ACCESS TO PRESCRIPTION DRUG BENEFITS


TUESDAY, FEBRUARY 15, 2000 - BEGINNING AT 1 :00 P.M.
ROOM 1100 LONGWORTH HOUSE OFFICE BUILDING


The Honorable David M. Walker, Comptroller General, U.S. General Accounting Office


PANEL:

Stephen B. Soumerai, ScD, Professor of Ambulatory Care and Prevention, and Director, Drug Policy Research Program, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts

John E. Calfee, Ph.D., Resident Scholar, American Enterprise Institute for Public Policy Research

Beatrice S. Braun, M.D., Member, Board of Directors, American Association of Retired Persons

Theodore D. Roth, President and Chief Operating Officer, Alliance Pharmaceutical Corporation, San Diego, California, on behalf of the California Healthcare Institute

Alan Sager, Ph.D., Professor, Boston University School of Public Health, Boston, Massachusetts